After treatment, the volume of CT26 tumor was only 1.1% as that of the PBS group, while the size of distant tumor was also considerably decreased, indicating that PDT accompanied with the IDO inhibitor successfully excited systemic antitumor immunity. Here, IDO1 is linked to neoplasm.